NASDAQ : PSNL
Personalis, Inc. — Key statistics
Healthcare · Diagnostics & Research · United States
Last price 15.925 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 1.70B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 1.69B |
| Enterprise Value | 1.51B |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 106.80M |
| Shares Outstanding | 106.80M |
| Shares Change (YoY) | +26.04% |
| Shares Change (QoQ) | +1.18% |
| Owned by Insiders (%) | 1.21% |
| Owned by Institutions (%) | 62.16% |
| Float | 86.37M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 24.34 |
| Forward PS | 17.76 |
| PB Ratio | 7.16 |
| P/TBV Ratio | 7.21 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 21.84 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 5.28 |
| Quick Ratio | 4.91 |
| Debt / Equity | 0.16 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -536.66 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -50.32% |
| Return on Assets (ROA) | -25.03% |
| Return on Invested Capital (ROIC) | -28.17% |
| Return on Capital Employed (ROCE) | -43.01% |
| Weighted Average Cost of Capital (WACC) | 16.66% |
| Revenue Per Employee | $267,958 |
| Profits Per Employee | -$412,227 |
| Employee Count | 260 |
| Asset Turnover | 0.24 |
| Inventory Turnover | 9.88 |
Taxes
| Measure | Value |
|---|
| Income Tax | 33,000 |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 2.32 |
| 52-Week Price Change | +64.32% |
| 50-Day Moving Average | 16.29 |
| 200-Day Moving Average | 11.32 |
| Relative Strength Index (RSI) | 45.95 |
| Average Volume (20 Days) | 2,407,050 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 6.79M |
| Short Previous Month | 8.43M |
| Short % of Shares Out | 6.36% |
| Short % of Float | 7.87% |
| Short Ratio (days to cover) | 2.95 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 69.67M |
| Gross Profit | 8.84M |
| Operating Income | -114.31M |
| Pretax Income | -107.15M |
| Net Income | -107.18M |
| EBITDA | -104.60M |
| EBIT | -114.31M |
| Loss Per Share | -$1.10 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 212.66M |
| Total Debt | 38.00M |
| Net Cash | 174.66M |
| Net Cash Per Share | $1.64 |
| Equity (Book Value) | 235.16M |
| Book Value Per Share | 2.21 |
| Working Capital | 198.67M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -92.30M |
| Capital Expenditures | -8.68M |
| Depreciation & Amortization | 9.71M |
| Net Borrowing | -4.26M |
| Free Cash Flow | -100.98M |
| FCF Per Share | -$0.95 |
Margins
| Measure | Value |
|---|
| Gross Margin | 12.69% |
| Operating Margin | -164.07% |
| Pretax Margin | -153.79% |
| Profit Margin | -153.84% |
| EBITDA Margin | -150.13% |
| EBIT Margin | -164.07% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -26.04% |
| Shareholder Yield | -26.04% |
| Earnings Yield | -6.94% |
| FCF Yield | -5.95% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $15.17 |
| Price Target Difference | -4.05% |
| Analyst Consensus | Hold |
| Analyst Count | 5 |
| Revenue Growth Forecast (3Y) | 28.19% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 2.37 |
| Piotroski F-Score | 1 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |